Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAB001 in mild to moderate distal subungual onychomycosis
NCT01208129Phase 3Terminated
- Sponsor
- Promius Pharma
- Start
- Sep 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NAB-001 in onychomycosis, sponsored by Promius Pharma. Started Sep 2010; status: terminated.
02
Drugs
NAB-001
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT01208129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208129.